Weikang Pharmaceutical (300878.SZ) issued an announcement that the company plans to use its own funds to buy back the public through centralized bidding transactions...
According to the Zhitong Finance App, Weikang Pharmaceutical (300878.SZ) announced that the company plans to use its own funds to repurchase the company's shares through centralized bidding transactions. The shares repurchased by the company will be used for employee stock ownership plans or equity incentives in the future according to the actual situation of the company. The total capital for the repurchase shall not be less than RMB 25 million (inclusive) and not more than RMB 50 million (inclusive). The implementation period for share repurchase shall not exceed 12 months from the date the board of directors of the company reviews and approves the share repurchase plan.